# TMDX — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-06. Informational only, not financial advice.

**Recommendation:** HOLD

**Scores (0–100):** Overall 6.2 · Fundamentals 6.8 · Technicals 3.5 · Growth 7.8 · Risk 7.5

## Summary

TMDX is a category-defining organ preservation platform trading at $68.86 after a brutal ~46% YTD drawdown, with strong underlying quality (45% ROE, 30% revenue growth, 59% gross margins) but a Q1 2026 margin collapse that halved operating margins and pushed FCF negative. The July 30 earnings print is the binary catalyst — the setup favors patience with a small starter position, since valuation (15.8x trailing, 20.3x fwd P/E) and 23% short interest create asymmetric potential if margins normalize, but downside remains real if Q1 was structural rather than transitory.

## Price targets (6-month horizon)

- Bear: $55.00
- Base: $78.00
- Bull: $100.00

## News context

News flow is mixed-to-constructive. TD Cowen reiterated Buy with a $120 target (implying ~74% upside), and Stifel raised its target from $75 to $80 while maintaining Hold — the sell-side is defending the story but not aggressively so. A Seeking Alpha piece explicitly frames the setup as the market over-reacting to Q1 margin pressure with the core growth thesis intact — a reasonable base-rate view for a name like this. A $722K insider sale after a 45% drop is a mild negative signal but is small in absolute dollars. ChartMill flagging TMDX as 'affordable growth' and Motley Fool's 10-year framing suggest the retail/quant crowd is starting to view this as a value-in-growth rebuild. Signal: consensus is that Q1 is a bump, not a break, but nobody is willing to underwrite that fully until the July 30 print. Noise: crypto/macro headlines are irrelevant to this specific setup.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/tmdx-ai-stock-forecast-b619b87e0c1e8d1736e49dbf8a781e0d
- AI-generated; model outputs can be wrong. Not financial advice.